Breast cancer:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Stamford, Conn.
JAI Press
©1998
|
| Schriftenreihe: | Advances in oncobiology
v. 2 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | Breast cancer research has never been in such an exciting and hopeful phase as today. From a clinical perspective, the discovery of genetic markers of risk in a proportion of familial breast cancer cases has opened up new vistas for understanding and ultimately preventing this disease. On the other hand, aggressive - even daring - therapies are being proven to be effective against advanced breast cancer. For the breast cancer experimentalist, this is also a time of great advance. Although animal and cell culture breast cancer models have proven to be of great use, there are now increasing opportunities to test the concepts developed in these models in actual clinical samples and cases. It is gratifying to see how well these concepts "translate" into the clinical setting. A very active area of research that is linking the laboratory to the clinic is the dissection of the biology and elucidation of the significance of proliferate breast disease and the identification of true, "high risk" or "preneoplastic" legions within the previously ill-defined spectrum of fibrocystic or benign breast disease. One anticipates that discoveries made here will also lead to earlier detection, intervention and prevention of life-threatening cancer. Even, however, as we look with optimism to the eventual eradication of breast cancer, we are once again forced to face the reality that we have not yet achieved our goal. Thus, we are saddened by the much too premature death of Dr. Helene Smith from breast cancer. Helena's work was at the forefront of efforts to understand the biology of human breast cancer at the molecular level. Her insight, open-mindedness, and refusal to sacrifice relevance for convenience will continue to set the standard for all breast cancer researchers. This volume is dedicated to her memory Includes bibliographical references and index |
| Beschreibung: | 1 Online-Ressource (x, 253 pages) |
| ISBN: | 9780762303885 0762303883 9780080526423 008052642X |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV042305422 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150129s1998 |||| o||u| ||||||eng d | ||
| 020 | |a 9780762303885 |9 978-0-7623-0388-5 | ||
| 020 | |a 0762303883 |9 0-7623-0388-3 | ||
| 020 | |a 9780080526423 |c electronic bk. |9 978-0-08-052642-3 | ||
| 020 | |a 008052642X |c electronic bk. |9 0-08-052642-X | ||
| 035 | |a (OCoLC)162130935 | ||
| 035 | |a (DE-599)BVBBV042305422 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 616.99449 |2 22 | |
| 245 | 1 | 0 | |a Breast cancer |c guest editors, William P. Peters, Daniel W. Visscher |
| 264 | 1 | |a Stamford, Conn. |b JAI Press |c ©1998 | |
| 300 | |a 1 Online-Ressource (x, 253 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in oncobiology |v v. 2 | |
| 500 | |a Breast cancer research has never been in such an exciting and hopeful phase as today. From a clinical perspective, the discovery of genetic markers of risk in a proportion of familial breast cancer cases has opened up new vistas for understanding and ultimately preventing this disease. On the other hand, aggressive - even daring - therapies are being proven to be effective against advanced breast cancer. For the breast cancer experimentalist, this is also a time of great advance. Although animal and cell culture breast cancer models have proven to be of great use, there are now increasing opportunities to test the concepts developed in these models in actual clinical samples and cases. It is gratifying to see how well these concepts "translate" into the clinical setting. A very active area of research that is linking the laboratory to the clinic is the dissection of the biology and elucidation of the significance of proliferate breast disease and the identification of true, "high risk" or "preneoplastic" legions within the previously ill-defined spectrum of fibrocystic or benign breast disease. One anticipates that discoveries made here will also lead to earlier detection, intervention and prevention of life-threatening cancer. Even, however, as we look with optimism to the eventual eradication of breast cancer, we are once again forced to face the reality that we have not yet achieved our goal. Thus, we are saddened by the much too premature death of Dr. Helene Smith from breast cancer. Helena's work was at the forefront of efforts to understand the biology of human breast cancer at the molecular level. Her insight, open-mindedness, and refusal to sacrifice relevance for convenience will continue to set the standard for all breast cancer researchers. This volume is dedicated to her memory | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Breast Neoplasms / genetics | |
| 650 | 4 | |a Breast Neoplasms / immunology | |
| 650 | 4 | |a Estrogens | |
| 650 | 4 | |a Growth Substances | |
| 650 | 4 | |a Breast neoplasms / Genetics | |
| 650 | 4 | |a Breast Neoplasms / Immunology | |
| 650 | 4 | |a Growth substances | |
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 7 | |a Breast / Cancer / Genetic aspects |2 fast | |
| 650 | 7 | |a Estrogen |2 fast | |
| 650 | 7 | |a Growth factors |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Breast |x Cancer |x Genetic aspects | |
| 650 | 4 | |a Estrogen | |
| 650 | 4 | |a Growth factors | |
| 700 | 1 | |a Peters, William P. |e Sonstige |4 oth | |
| 700 | 1 | |a Visscher, Daniel W. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780762303885 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 940 | 1 | |q FAW_PDA_ESD | |
| 940 | 1 | |q FLA_PDA_ESD | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027742414 | ||
Datensatz im Suchindex
| _version_ | 1804152888483643392 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042305422 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (OCoLC)162130935 (DE-599)BVBBV042305422 |
| dewey-full | 616.99449 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99449 |
| dewey-search | 616.99449 |
| dewey-sort | 3616.99449 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03764nmm a2200589zcb4500</leader><controlfield tag="001">BV042305422</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s1998 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780762303885</subfield><subfield code="9">978-0-7623-0388-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0762303883</subfield><subfield code="9">0-7623-0388-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080526423</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-08-052642-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">008052642X</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-08-052642-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)162130935</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042305422</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99449</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Breast cancer</subfield><subfield code="c">guest editors, William P. Peters, Daniel W. Visscher</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Stamford, Conn.</subfield><subfield code="b">JAI Press</subfield><subfield code="c">©1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 253 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in oncobiology</subfield><subfield code="v">v. 2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Breast cancer research has never been in such an exciting and hopeful phase as today. From a clinical perspective, the discovery of genetic markers of risk in a proportion of familial breast cancer cases has opened up new vistas for understanding and ultimately preventing this disease. On the other hand, aggressive - even daring - therapies are being proven to be effective against advanced breast cancer. For the breast cancer experimentalist, this is also a time of great advance. Although animal and cell culture breast cancer models have proven to be of great use, there are now increasing opportunities to test the concepts developed in these models in actual clinical samples and cases. It is gratifying to see how well these concepts "translate" into the clinical setting. A very active area of research that is linking the laboratory to the clinic is the dissection of the biology and elucidation of the significance of proliferate breast disease and the identification of true, "high risk" or "preneoplastic" legions within the previously ill-defined spectrum of fibrocystic or benign breast disease. One anticipates that discoveries made here will also lead to earlier detection, intervention and prevention of life-threatening cancer. Even, however, as we look with optimism to the eventual eradication of breast cancer, we are once again forced to face the reality that we have not yet achieved our goal. Thus, we are saddened by the much too premature death of Dr. Helene Smith from breast cancer. Helena's work was at the forefront of efforts to understand the biology of human breast cancer at the molecular level. Her insight, open-mindedness, and refusal to sacrifice relevance for convenience will continue to set the standard for all breast cancer researchers. This volume is dedicated to her memory</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms / genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms / immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogens</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Growth Substances</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast neoplasms / Genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms / Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Growth substances</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast / Cancer / Genetic aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Estrogen</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Growth factors</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Genetic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogen</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Growth factors</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peters, William P.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Visscher, Daniel W.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780762303885</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_ESD</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027742414</subfield></datafield></record></collection> |
| id | DE-604.BV042305422 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:17:52Z |
| institution | BVB |
| isbn | 9780762303885 0762303883 9780080526423 008052642X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027742414 |
| oclc_num | 162130935 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource (x, 253 pages) |
| psigel | ZDB-33-ESD ZDB-33-EBS FAW_PDA_ESD FLA_PDA_ESD |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | JAI Press |
| record_format | marc |
| series2 | Advances in oncobiology |
| spelling | Breast cancer guest editors, William P. Peters, Daniel W. Visscher Stamford, Conn. JAI Press ©1998 1 Online-Ressource (x, 253 pages) txt rdacontent c rdamedia cr rdacarrier Advances in oncobiology v. 2 Breast cancer research has never been in such an exciting and hopeful phase as today. From a clinical perspective, the discovery of genetic markers of risk in a proportion of familial breast cancer cases has opened up new vistas for understanding and ultimately preventing this disease. On the other hand, aggressive - even daring - therapies are being proven to be effective against advanced breast cancer. For the breast cancer experimentalist, this is also a time of great advance. Although animal and cell culture breast cancer models have proven to be of great use, there are now increasing opportunities to test the concepts developed in these models in actual clinical samples and cases. It is gratifying to see how well these concepts "translate" into the clinical setting. A very active area of research that is linking the laboratory to the clinic is the dissection of the biology and elucidation of the significance of proliferate breast disease and the identification of true, "high risk" or "preneoplastic" legions within the previously ill-defined spectrum of fibrocystic or benign breast disease. One anticipates that discoveries made here will also lead to earlier detection, intervention and prevention of life-threatening cancer. Even, however, as we look with optimism to the eventual eradication of breast cancer, we are once again forced to face the reality that we have not yet achieved our goal. Thus, we are saddened by the much too premature death of Dr. Helene Smith from breast cancer. Helena's work was at the forefront of efforts to understand the biology of human breast cancer at the molecular level. Her insight, open-mindedness, and refusal to sacrifice relevance for convenience will continue to set the standard for all breast cancer researchers. This volume is dedicated to her memory Includes bibliographical references and index Breast Neoplasms / genetics Breast Neoplasms / immunology Estrogens Growth Substances Breast neoplasms / Genetics Breast Neoplasms / Immunology Growth substances MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Breast / Cancer / Genetic aspects fast Estrogen fast Growth factors fast Medizin Breast Cancer Genetic aspects Estrogen Growth factors Peters, William P. Sonstige oth Visscher, Daniel W. Sonstige oth http://www.sciencedirect.com/science/book/9780762303885 Verlag Volltext |
| spellingShingle | Breast cancer Breast Neoplasms / genetics Breast Neoplasms / immunology Estrogens Growth Substances Breast neoplasms / Genetics Breast Neoplasms / Immunology Growth substances MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Breast / Cancer / Genetic aspects fast Estrogen fast Growth factors fast Medizin Breast Cancer Genetic aspects Estrogen Growth factors |
| title | Breast cancer |
| title_auth | Breast cancer |
| title_exact_search | Breast cancer |
| title_full | Breast cancer guest editors, William P. Peters, Daniel W. Visscher |
| title_fullStr | Breast cancer guest editors, William P. Peters, Daniel W. Visscher |
| title_full_unstemmed | Breast cancer guest editors, William P. Peters, Daniel W. Visscher |
| title_short | Breast cancer |
| title_sort | breast cancer |
| topic | Breast Neoplasms / genetics Breast Neoplasms / immunology Estrogens Growth Substances Breast neoplasms / Genetics Breast Neoplasms / Immunology Growth substances MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Breast / Cancer / Genetic aspects fast Estrogen fast Growth factors fast Medizin Breast Cancer Genetic aspects Estrogen Growth factors |
| topic_facet | Breast Neoplasms / genetics Breast Neoplasms / immunology Estrogens Growth Substances Breast neoplasms / Genetics Breast Neoplasms / Immunology Growth substances MEDICAL / Oncology HEALTH & FITNESS / Diseases / Cancer Breast / Cancer / Genetic aspects Estrogen Growth factors Medizin Breast Cancer Genetic aspects |
| url | http://www.sciencedirect.com/science/book/9780762303885 |
| work_keys_str_mv | AT peterswilliamp breastcancer AT visscherdanielw breastcancer |